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The title is from the programme of the 5th South African AIDS 
conference1 held in Durban in June. The conference brought together 
clinical scientists, basic scientists, educators and learners, law and 
human rights experts, practitioners (doctors, nurses, community 
carers), community workers, NGOs, members of civil society 
and lay members of so-called key populations (e.g. sex workers), 
pharmaceutical industry representatives, people from the world of 
work, politicians and policy makers.
June 2011 marked the 30th anniversary of the recognition of the 
pandemic, then manifesting in New York as outbreaks among the 
gay population of Kaposi’s sarcoma and pneumocystis pneumonia in 
ostensibly healthy young men. A year later the Centers for Disease 
Control coined the term ‘acquired immune deficiency syndrome’ – 
AIDS. 
A soaring death rate led to a scramble to identify the cause. 
Assigning credit for the discovery of HIV was controversial, but it 
is agreed that Robert Gallo, a ‘retrovirologist’ at the National Cancer 
Institute, Maryland, Luc Montagnier and their research groups 
contributed significantly. Montagnier’s group first isolated HIV, 
while Gallo’s group demonstrated that the virus causes AIDS and 
generated much of the science that made the discovery possible, 
including a technique previously developed by Gallo’s laboratory 
for growing T cells in the lab.2 There have since been breathtaking 
scientific advances, and understanding of the virus’s structure, mode 
of replication and targeting of the immune system have led to the 
development of drug therapy to restore immunity, although not yet to 
cure infection, and tools and methods to limit transmission. 
South Africa has proved particularly vulnerable. While having 
0.7% of the world population we carry 17% of the global HIV burden, 
and 1 out of every 100 South Africans has tuberculosis. The Durban 
conference celebrated the enormous continuing contributions 
by South African professional and lay health communities. Our 
scientists and practitioners have played pivotal roles in the field, 
many reported in this journal and its sister, the South African 
Journal of HIV Medicine. The dark days of denialism have ended 
and reduction of a vicious epidemic is envisioned on the back of the 
National Department of Health’s Strategic Priority Framework for 
the New HIV/STI and TB National Strategic Plan and New Primary 
Healthcare Revitalisation Programme. The health system’s robust 
new approach encompasses a massive HIV counselling and testing 
(test one – test all) campaign, antiretroviral (ARV) treatment and 
expansion of medical male circumcision.3
The Conference also saw the launch of an operational plan aimed 
at implementing the UNAIDS Accelerated Agenda for Women, 
Girls, Gender Equality and HIV. This calls for national responses 
to anticipate and address the particular vulnerability of women and 
girls to HIV. 
In June we also celebrated the 10th anniversary of the 
commencement of the Médecins Sans Frontières (MSF) programme 
in Khayelitsha, which has showed that people in impoverished areas 
are capable of adhering to schedules for taking a cocktail of drugs. As 
Vuyiseka Dubula of the Treatment Action Campaign, South Africa’s 
best known AIDS activist organisation, has said: ‘The West or the 
northern world said we were too poor to treat: “They can’t even tell 
the time.” To their surprise, we beat them on adherence. We adhere 
better than they do.’ One of the MSF clinic’s first AIDS patients was 
losing weight, vomiting and sick with diarrhoea in 2001, and 10 years 
later claims that but for the programme ‘I would not have received 
this treatment and I would not have survived.’4 Now one million 
South Africans receive anti-AIDS drugs.
Significant breakthroughs occurred in 2010 in developing biomedical 
prevention tools for HIV. South African communities, health workers 
and scientists contributed significantly to these developments, including 
synthesis of microbicides, pre-exposure HIV prophylaxis and vaccines. 
In a trial of couples where one partner was HIV positive and the other 
negative, if the HIV-positive partner was on ARV medication, their 
partner was protected from infection by a massive 96%.5 Francois 
Venter, President of the Southern African HIV Clinicians Society, 
stated that this is ‘possibly one of the most important HIV studies of 
the decade’. 1 Male circumcision offers 54% protection from HIV, while 
a study of gay men found that taking an ARV called Truvada before 
sex could prevent HIV transmission by 44%. A trial in Tanzania found 
that if sexually transmitted infections were treated, transmission was 
reduced by 42%. Finally, a microbicide vaginal gel containing the ARV 
tenofovir can reduce HIV infection by 39%.6
South Africa seems set to enter an era of HIV management with 
the prospect of arresting the epidemic! More must be done, of course, 
not least to offer all who test HIV positive ARV therapy timeously 
and before immunity is imperilled, i.e. at a CD4 count of 350 cells/µl. 
This explains the appeal to health professionals by Finance Minister 
Pravin Gordhan that we pressure the pharmaceutical industry to 
ensure that developing countries get cheaper ARV medication. He 
cited the billions of rands saved in awarding the recent ARV tender 
following an approach that involved greater interaction between the 
Treasury and the Health Department.
Most of all, South Africa 
needs to adopt a ‘no more 
whispers’ policy to put an end 
to discrimination against people 
living with HIV/AIDS and to 
ensure that no greater shame or 
stigma attaches to being HIV 
infected than it does to having 
TB or being epileptic.
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